Trip.com Group’s U.S.-listed ADSs (TCOM) traded lower as investors revisited two linked overhangs: an ongoing antitrust investigation in China and a wave of U.S. securities class-action announcements that continue to generate negative headlines. The China probe centers on an investigation opened by the State Administration for Market Regulation (SAMR) under the PRC Anti-Monopoly Law, which Trip.com has said it is cooperating with. (mlex.com)

Multiple law-firm notices and reminders have circulated in March reiterating the class period allegations tied to the antitrust investigation disclosure and emphasizing a May 11, 2026 deadline for investors to seek lead-plaintiff status. This steady flow of litigation-related headlines has been a recurring short-term catalyst for downside moves, even as the company has recently reported strong 2025 results. (marketchameleon.com)

Near-term attention is likely to remain on any incremental signal from regulators about scope, potential remedies, or timing for the SAMR process, as well as whether additional plaintiffs’ filings or court developments intensify the legal narrative. Investors will also watch whether operational performance and travel demand data can keep the fundamental story in focus while regulatory uncertainty persists. (stocktitan.net)